[{"text": "Translator: Joseph Geni\nReviewer: Morton Bast", "start": 0.0, "duration": 7.0}, {"text": "I'd like to share with you", "start": 16.837, "duration": 1.996}, {"text": "the story of one of my patients called Celine.", "start": 18.833, "duration": 3.837}, {"text": "Celine is a housewife and lives in a rural district", "start": 22.67, "duration": 3.153}, {"text": "of Cameroon in west Central Africa.", "start": 25.823, "duration": 3.072}, {"text": "Six years ago, at the time of her HIV diagnosis,", "start": 28.895, "duration": 3.687}, {"text": "she was recruited to participate in the clinical trial", "start": 32.582, "duration": 3.001}, {"text": "which was running in her health district at the time.", "start": 35.583, "duration": 3.071}, {"text": "When I first met Celine, a little over a year ago,", "start": 38.654, "duration": 3.704}, {"text": "she had gone for 18 months", "start": 42.358, "duration": 1.684}, {"text": "without any antiretroviral therapy,", "start": 44.042, "duration": 2.287}, {"text": "and she was very ill.", "start": 46.329, "duration": 2.737}, {"text": "She told me that she stopped coming to the clinic", "start": 49.066, "duration": 2.398}, {"text": "when the trial ended", "start": 51.464, "duration": 1.551}, {"text": "because she had no money for the bus fare", "start": 53.015, "duration": 2.711}, {"text": "and was too ill to walk the 35-kilometer distance.", "start": 55.726, "duration": 3.728}, {"text": "Now during the clinical trial,", "start": 59.454, "duration": 1.744}, {"text": "she'd been given all her antiretroviral drugs free of charge,", "start": 61.198, "duration": 4.385}, {"text": "and her transportation costs", "start": 65.583, "duration": 2.031}, {"text": "had been covered by the research funds.", "start": 67.614, "duration": 2.607}, {"text": "All of these ended once the trial was completed,", "start": 70.221, "duration": 3.354}, {"text": "leaving Celine with no alternatives.", "start": 73.575, "duration": 2.992}, {"text": "She was unable to tell me the names of the drugs", "start": 76.567, "duration": 2.676}, {"text": "she'd received during the trial,", "start": 79.243, "duration": 2.027}, {"text": "or even what the trial had been about.", "start": 81.27, "duration": 2.757}, {"text": "I didn't bother to ask her what the results of the trial were", "start": 84.027, "duration": 3.549}, {"text": "because it seemed obvious to me that she would have no clue.", "start": 87.576, "duration": 4.407}, {"text": "Yet what puzzled me most", "start": 91.983, "duration": 2.269}, {"text": "was Celine had given her informed consent", "start": 94.252, "duration": 3.107}, {"text": "to be a part of this trial, yet she clearly did not understand", "start": 97.359, "duration": 3.832}, {"text": "the implications of being a participant", "start": 101.191, "duration": 2.47}, {"text": "or what would happen to her once the trial had been completed.", "start": 103.661, "duration": 4.409}, {"text": "Now, I have shared this story with you as an example", "start": 108.07, "duration": 3.395}, {"text": "of what can happen to participants in the clinical trial", "start": 111.465, "duration": 2.929}, {"text": "when it is poorly conducted.", "start": 114.394, "duration": 2.459}, {"text": "Maybe this particular trial yielded exciting results.", "start": 116.853, "duration": 3.865}, {"text": "Maybe it even got published in a high-profile scientific journal.", "start": 120.718, "duration": 3.689}, {"text": "Maybe it would inform clinicians around the world", "start": 124.407, "duration": 2.807}, {"text": "on how to improve on the clinical management of HIV patients.", "start": 127.214, "duration": 5.535}, {"text": "But it would have done so at a price", "start": 132.749, "duration": 2.786}, {"text": "to hundreds of patients who, like Celine,", "start": 135.535, "duration": 2.947}, {"text": "were left to their own devices", "start": 138.482, "duration": 2.244}, {"text": "once the research had been completed.", "start": 140.726, "duration": 3.071}, {"text": "I do not stand here today to suggest in any way", "start": 143.797, "duration": 3.338}, {"text": "that conducting HIV clinical trials", "start": 147.135, "duration": 2.013}, {"text": "in developing countries is bad.", "start": 149.148, "duration": 2.215}, {"text": "On the contrary, clinical trials are extremely useful tools,", "start": 151.363, "duration": 4.367}, {"text": "and are much needed to address the burden", "start": 155.73, "duration": 2.298}, {"text": "of disease in developing countries.", "start": 158.028, "duration": 2.471}, {"text": "However, the inequalities that exist between", "start": 160.499, "duration": 2.859}, {"text": "richer countries and developing countries in terms of funding", "start": 163.358, "duration": 3.702}, {"text": "pose a real risk for exploitation,", "start": 167.06, "duration": 3.157}, {"text": "especially in the context of externally-funded research.", "start": 170.217, "duration": 3.885}, {"text": "Sadly enough, the fact remains that", "start": 174.102, "duration": 2.606}, {"text": "a lot of the studies that are conducted in developing countries", "start": 176.708, "duration": 3.984}, {"text": "could never be authorized in the richer countries", "start": 180.692, "duration": 2.576}, {"text": "which fund the research.", "start": 183.268, "duration": 2.248}, {"text": "I'm sure you must be asking yourselves", "start": 185.516, "duration": 2.247}, {"text": "what makes developing countries,", "start": 187.763, "duration": 1.916}, {"text": "especially those in sub-Saharan Africa,", "start": 189.679, "duration": 2.544}, {"text": "so attractive for these HIV clinical trials?", "start": 192.223, "duration": 3.567}, {"text": "Well, in order for a clinical trial to generate", "start": 195.79, "duration": 3.272}, {"text": "valid and widely applicable results,", "start": 199.062, "duration": 3.116}, {"text": "they need to be conducted with large numbers of study participants", "start": 202.178, "duration": 4.0}, {"text": "and preferably on a population", "start": 206.178, "duration": 2.643}, {"text": "with a high incidence of new HIV infections.", "start": 208.821, "duration": 3.781}, {"text": "Sub-Saharan Africa largely fits this description,", "start": 212.602, "duration": 3.471}, {"text": "with 22 million people living with HIV,", "start": 216.073, "duration": 3.202}, {"text": "an estimated 70 percent of the 30 million people", "start": 219.275, "duration": 3.64}, {"text": "who are infected worldwide.", "start": 222.915, "duration": 2.481}, {"text": "Also, research within the continent", "start": 225.396, "duration": 2.43}, {"text": "is a lot easier to conduct due to widespread poverty,", "start": 227.826, "duration": 4.112}, {"text": "endemic diseases and inadequate health care systems.", "start": 231.938, "duration": 3.851}, {"text": "A clinical trial that is considered to be", "start": 235.789, "duration": 2.789}, {"text": "potentially beneficial to the population", "start": 238.578, "duration": 2.75}, {"text": "is more likely to be authorized,", "start": 241.328, "duration": 2.307}, {"text": "and in the absence of good health care systems,", "start": 243.635, "duration": 2.8}, {"text": "almost any offer of medical assistance", "start": 246.435, "duration": 2.954}, {"text": "is accepted as better than nothing.", "start": 249.389, "duration": 2.918}, {"text": "Even more problematic reasons include", "start": 252.307, "duration": 2.586}, {"text": "lower risk of litigation,", "start": 254.893, "duration": 2.287}, {"text": "less rigorous ethical reviews,", "start": 257.18, "duration": 2.467}, {"text": "and populations that are willing to participate", "start": 259.647, "duration": 2.556}, {"text": "in almost any study that hints at a cure.", "start": 262.203, "duration": 4.664}, {"text": "As funding for HIV research", "start": 266.867, "duration": 3.625}, {"text": "increases in developing countries", "start": 270.492, "duration": 2.256}, {"text": "and ethical review in richer countries become more strict,", "start": 272.748, "duration": 4.007}, {"text": "you can see why this context becomes", "start": 276.755, "duration": 2.085}, {"text": "very, very attractive.", "start": 278.84, "duration": 2.561}, {"text": "The high prevalence of HIV drives researchers", "start": 281.401, "duration": 3.68}, {"text": "to conduct research that is sometimes scientifically acceptable", "start": 285.081, "duration": 4.484}, {"text": "but on many levels ethically questionable.", "start": 289.565, "duration": 3.279}, {"text": "How then can we ensure that, in our search for the cure,", "start": 292.844, "duration": 3.439}, {"text": "we do not take an unfair advantage", "start": 296.283, "duration": 2.32}, {"text": "of those who are already most affected by the pandemic?", "start": 298.603, "duration": 3.504}, {"text": "I invite you to consider four areas I think we can focus on", "start": 302.107, "duration": 3.856}, {"text": "in order to improve the way in which things are done.", "start": 305.963, "duration": 3.575}, {"text": "The first of these is informed consent.", "start": 309.538, "duration": 2.827}, {"text": "Now, in order for a clinical trial to be", "start": 312.365, "duration": 2.368}, {"text": "considered ethically acceptable,", "start": 314.733, "duration": 3.681}, {"text": "participants must be given the relevant information", "start": 318.414, "duration": 2.824}, {"text": "in a way in which they can understand,", "start": 321.238, "duration": 2.435}, {"text": "and must freely consent to participate in the trial.", "start": 323.673, "duration": 4.217}, {"text": "This is especially important in developing countries,", "start": 327.89, "duration": 2.678}, {"text": "where a lot of participants consent to research", "start": 330.568, "duration": 2.902}, {"text": "because they believe it is the only way in which", "start": 333.47, "duration": 2.688}, {"text": "they can receive medical care or other benefits.", "start": 336.158, "duration": 3.57}, {"text": "Consent procedures that are used in richer countries", "start": 339.728, "duration": 2.967}, {"text": "are often inappropriate or ineffective", "start": 342.695, "duration": 2.802}, {"text": "in a lot of developing countries.", "start": 345.497, "duration": 2.353}, {"text": "For example, it is counterintuitive to have", "start": 347.85, "duration": 2.973}, {"text": "an illiterate study participant, like Celine,", "start": 350.823, "duration": 2.999}, {"text": "sign a lengthy consent form that they are unable to read,", "start": 353.822, "duration": 3.327}, {"text": "let alone understand.", "start": 357.149, "duration": 2.107}, {"text": "Local communities need to be more involved", "start": 359.256, "duration": 3.08}, {"text": "in establishing the criteria for recruiting participants", "start": 362.336, "duration": 3.273}, {"text": "in clinical trials, as well as the incentives for participation.", "start": 365.609, "duration": 4.701}, {"text": "The information in these trials", "start": 370.31, "duration": 1.816}, {"text": "needs to be given to the potential participants", "start": 372.126, "duration": 2.951}, {"text": "in linguistically and culturally acceptable formats.", "start": 375.077, "duration": 4.428}, {"text": "The second point I would like for you to consider", "start": 379.505, "duration": 2.821}, {"text": "is the standard of care that is provided", "start": 382.326, "duration": 2.438}, {"text": "to participants within any clinical trial.", "start": 384.764, "duration": 2.946}, {"text": "Now, this is subject to a lot of debate and controversy.", "start": 387.71, "duration": 3.697}, {"text": "Should the control group in the clinical trial", "start": 391.407, "duration": 2.981}, {"text": "be given the best current treatment which is available", "start": 394.388, "duration": 3.273}, {"text": "anywhere in the world?", "start": 397.661, "duration": 2.08}, {"text": "Or should they be given an alternative standard of care,", "start": 399.741, "duration": 2.968}, {"text": "such as the best current treatment available", "start": 402.709, "duration": 2.888}, {"text": "in the country in which the research is being conducted?", "start": 405.597, "duration": 3.312}, {"text": "Is it fair to evaluate a treatment regimen", "start": 408.909, "duration": 3.34}, {"text": "which may not be affordable or accessible", "start": 412.249, "duration": 3.076}, {"text": "to the study participants once the research has been completed?", "start": 415.325, "duration": 3.97}, {"text": "Now, in a situation where the best current treatment", "start": 419.295, "duration": 3.741}, {"text": "is inexpensive and simple to deliver,", "start": 423.036, "duration": 2.639}, {"text": "the answer is straightforward.", "start": 425.675, "duration": 2.028}, {"text": "However, the best current treatment available", "start": 427.703, "duration": 3.15}, {"text": "anywhere in the world is often very difficult", "start": 430.853, "duration": 2.887}, {"text": "to provide in developing countries.", "start": 433.74, "duration": 2.687}, {"text": "It is important to assess the potential risks and benefits", "start": 436.427, "duration": 3.552}, {"text": "of the standard of care which is to be provided", "start": 439.979, "duration": 2.777}, {"text": "to participants in any clinical trial,", "start": 442.756, "duration": 2.481}, {"text": "and establish one which is relevant for the context of the study", "start": 445.237, "duration": 5.448}, {"text": "and most beneficial for the participants within the study.", "start": 450.685, "duration": 3.497}, {"text": "That brings us to the third point I want you think about:", "start": 454.182, "duration": 3.251}, {"text": "the ethical review of research.", "start": 457.433, "duration": 2.851}, {"text": "An effective system for reviewing the ethical suitability", "start": 460.284, "duration": 3.799}, {"text": "of clinical trials is primordial to safeguard participants", "start": 464.083, "duration": 4.128}, {"text": "within any clinical trial.", "start": 468.211, "duration": 2.113}, {"text": "Unfortunately, this is often lacking", "start": 470.324, "duration": 2.912}, {"text": "or inefficient in a lot of developing countries.", "start": 473.236, "duration": 3.528}, {"text": "Local governments need to set up effective systems", "start": 476.764, "duration": 4.363}, {"text": "for reviewing the ethical issues around the clinical trials", "start": 481.127, "duration": 2.877}, {"text": "which are authorized in different developing countries,", "start": 484.004, "duration": 3.917}, {"text": "and they need to do this by setting up", "start": 487.921, "duration": 2.274}, {"text": "ethical review committees that are independent", "start": 490.195, "duration": 2.51}, {"text": "of the government and research sponsors.", "start": 492.705, "duration": 3.385}, {"text": "Public accountability needs to be promoted", "start": 496.09, "duration": 2.41}, {"text": "through transparency and independent review", "start": 498.5, "duration": 3.233}, {"text": "by nongovernmental and international organizations", "start": 501.733, "duration": 3.039}, {"text": "as appropriate.", "start": 504.772, "duration": 1.571}, {"text": "The final point I would like for you to consider tonight", "start": 506.343, "duration": 3.51}, {"text": "is what happens to participants in the clinical trial", "start": 509.853, "duration": 3.223}, {"text": "once the research has been completed.", "start": 513.076, "duration": 2.775}, {"text": "I think it is absolutely wrong for research to begin", "start": 515.851, "duration": 3.474}, {"text": "in the first place without a clear plan", "start": 519.325, "duration": 2.512}, {"text": "for what would happen to the participants", "start": 521.837, "duration": 2.079}, {"text": "once the trial has ended.", "start": 523.916, "duration": 2.44}, {"text": "Now, researchers need to make every effort to ensure that", "start": 526.356, "duration": 5.128}, {"text": "an intervention that has been shown to be beneficial", "start": 531.484, "duration": 2.984}, {"text": "during a clinical trial", "start": 534.468, "duration": 1.732}, {"text": "is accessible to the participants of the trial", "start": 536.2, "duration": 3.612}, {"text": "once the trial has been completed.", "start": 539.812, "duration": 2.548}, {"text": "In addition, they should be able to consider the possibility", "start": 542.36, "duration": 3.524}, {"text": "of introducing and maintaining effective treatments", "start": 545.884, "duration": 3.601}, {"text": "in the wider community once the trial ends.", "start": 549.485, "duration": 3.841}, {"text": "If, for any reason, they feel that this might not be possible,", "start": 553.326, "duration": 3.423}, {"text": "then I think they should have to ethically justify", "start": 556.749, "duration": 2.967}, {"text": "why the clinical trial should be conducted in the first place.", "start": 559.716, "duration": 4.027}, {"text": "Now, fortunately for Celine,", "start": 563.743, "duration": 2.316}, {"text": "our meeting did not end in my office.", "start": 566.059, "duration": 2.675}, {"text": "I was able to get her enrolled into a free HIV treatment program", "start": 568.734, "duration": 4.374}, {"text": "closer to her home,", "start": 573.108, "duration": 1.388}, {"text": "and with a support group to help her cope.", "start": 574.496, "duration": 3.774}, {"text": "Her story has a positive ending,", "start": 578.27, "duration": 2.334}, {"text": "but there are thousands of others in similar situations", "start": 580.604, "duration": 3.703}, {"text": "who are much less fortunate.", "start": 584.307, "duration": 2.297}, {"text": "Although she may not know this,", "start": 586.604, "duration": 2.424}, {"text": "my encounter with Celine has completely changed the way", "start": 589.028, "duration": 3.865}, {"text": "in which I view HIV clinical trials in developing countries,", "start": 592.893, "duration": 4.271}, {"text": "and made me even more determined to be part of the movement", "start": 597.164, "duration": 3.72}, {"text": "to change the way in which things are done.", "start": 600.884, "duration": 2.857}, {"text": "I believe that every single person", "start": 603.741, "duration": 2.368}, {"text": "listening to me tonight can be part of that change.", "start": 606.109, "duration": 4.375}, {"text": "If you are a researcher, I hold you", "start": 610.484, "duration": 2.597}, {"text": "to a higher standard of moral conscience,", "start": 613.081, "duration": 2.57}, {"text": "to remain ethical in your research,", "start": 615.651, "duration": 2.427}, {"text": "and not compromise human welfare in your search for answers.", "start": 618.078, "duration": 3.488}, {"text": "If you work for a funding agency or pharmaceutical company,", "start": 621.566, "duration": 3.678}, {"text": "I challenge you to hold your employers", "start": 625.244, "duration": 3.03}, {"text": "to fund research that is ethically sound.", "start": 628.274, "duration": 3.175}, {"text": "If you come from a developing country like myself,", "start": 631.449, "duration": 3.186}, {"text": "I urge you to hold your government", "start": 634.635, "duration": 3.072}, {"text": "to a more thorough review of the clinical trials", "start": 637.707, "duration": 2.616}, {"text": "which are authorized in your country.", "start": 640.323, "duration": 2.913}, {"text": "Yes, there is a need for us to find a cure for HIV,", "start": 643.236, "duration": 3.668}, {"text": "to find an effective vaccine for malaria,", "start": 646.904, "duration": 2.652}, {"text": "to find a diagnostic tool that works for T.B.,", "start": 649.556, "duration": 3.842}, {"text": "but I believe that we owe it to those who willingly", "start": 653.398, "duration": 3.575}, {"text": "and selflessly consent to participate in these clinical trials", "start": 656.973, "duration": 4.055}, {"text": "to do this in a humane way.", "start": 661.028, "duration": 2.226}, {"text": "Thank you.", "start": 663.254, "duration": 2.327}]